MedTrace Logo

Indonesian-Language Application-Based Guided Imagery Therapy for Insomnia and Glycemic Control in Diabetic Patients

NCT07141940 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2025-08-26

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if guided imagery therapy using mobile application in Indonesian language can improve sleep quality and lower fasting blood glucose levels in diabetics patients who have problems with their sleep.

The main questions it aims to answer are:

* Can the app-based guided imagery therapy help improve sleep quality in diabetic patients who have trouble sleeping?
* Can the app-based guided imagery therapy help lowering fasting blood glucose in diabetic patients who have trouble sleeping? Researchers will compare app-based guided imagery therapy to education about how to sleep well, to see if the app works to improve sleep quality and lower blood glucose.

Participants will:

* Receive education about how to sleep well
* Use the app 3 times a week for 4 weeks (only for group who receive the app)
* Visit the clinic after 4 weeks for tests

Conditions

  • Diabetes (Insulin-requiring, Type 1 or Type 2)
  • Insomnia Type; Sleep Disorder
  • Fasting Plasma Glucose

Interventions

OTHER

Indonesian-language application-based auditory guided imagery therapy

This study used a mobile application developed by researchers using Indonesian language to deliver an auditory guided imagery therapy

OTHER

Psychoeducation

Psychoeducation consists of sleep hygiene and relaxation therapy (breathing exercise, progressive muscle relaxation, and guided imagery)

Sponsors & Collaborators

  • Dr Cipto Mangunkusumo General Hospital

    lead OTHER

Principal Investigators

  • Rudi Putranto, Internist, MPH, PhD · Division of Psychosomatic and Palliative, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-06
Primary Completion
2025-08-19
Completion
2025-08-19

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07141940 on ClinicalTrials.gov